SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-039357
Filing Date
2023-08-14
Accepted
2023-08-14 06:01:20
Documents
13
Period of Report
2023-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20056996_8k.htm   iXBRL 8-K 42793
2 EXHIBIT 99.1 brhc20056996_ex99-1.htm EX-99.1 655564
  Complete submission text file 0001140361-23-039357.txt   879276

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20230814.xsd EX-101.SCH 3907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20230814_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20230814_pre.xml EX-101.PRE 16072
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc20056996_8k_htm.xml XML 4211
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 231165956
SIC: 2834 Pharmaceutical Preparations